Company intelligence

CRBP

Corbus Pharmaceuticals Holdings, Inc. · NASDAQ · Healthcare

Price$11.27-0.35% · −$0.04

Market cap208.81MEquity value

P / E-1.8Trailing ratio

Volume209.13KLatest session

Market data

CRBP price chart

TradingView

Related signals

1 min delayed

Browse public CRBP signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CRBPSep 23, 2024-7.73% since signal

Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now

CRBP received buy ratings from H.C. Wainwright and Oppenheimer this week. Analysts highlight a diversified pipeline as a growth driver. Maldonado believes Novo's drug issues won't affect CRB-913's potential. Oppenheimer targets $88, focusing on CRB-913 and CRB-701. Mizuho views the recent stock drop as an overreaction.

View signal analysis

Research